Department of Anesthesiology, Shanxi Provincial People's Hospital, Taiyuan, China.
Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China.
Int J Exp Pathol. 2021 Jun;102(3):140-147. doi: 10.1111/iep.12391. Epub 2021 Apr 21.
This study aimed to investigate the effect of cell surface CD47 downregulation on ischaemia-reperfusion injury (IRI) during pig liver transplantation. Blood samples were collected from healthy miniature Bama pigs randomly and equally divided into CD47 antagonism (group A), without CD47 antagonism (group B) and a sham group (group C). Blood samples were collected from groups A and B at 0, 8 and 48 hours after establishment of the new liver through an indwelling tube in the right internal jugular vein. Blood samples were collected at the same time points after liver dissociation from group C. The expression of interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) was detected by enzyme-linked immunosorbent assay (ELISA); CD47 expression was detected by Western blot; and liver function indices, including alanine aminotransferase (ALT) and aspartic transaminase (AST), were directly read by an automatic biochemical analyzer. The concentrations of both receptors in group A were significantly lower than groups B and C, at 8 and 48 hours after establishment of blood flow. At 8 and 48 hours in the new liver stage, the values of CD47 levels, ALT and AST in group A were significantly reduced compared to groups B and C (P < 0.05). The levels of CD47 in the three groups were consistent with the trends of the aforementioned observation indicators. The liver functions of the recipients were significantly improved by reducing the release of the inflammatory mediators. This study provides new ideas and intervention approaches for the treatment of IRI in liver transplantation.
本研究旨在探讨细胞表面 CD47 下调对猪肝移植缺血再灌注损伤 (IRI) 的影响。随机采集健康小型巴马猪血液样本,并均等分为 CD47 拮抗组(A 组)、无 CD47 拮抗组(B 组)和假手术组(C 组)。通过右颈内静脉留置管于 A、B 组新肝建立后 0、8、48 小时采集血样,C 组于肝分离时于相同时间点采集血样。采用酶联免疫吸附试验(ELISA)检测白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)的表达;采用 Western blot 检测 CD47 表达;采用自动生化分析仪直接读取丙氨酸氨基转移酶(ALT)和天门冬氨酸氨基转移酶(AST)等肝功能指标。A 组的两种受体浓度在新肝建立后 8 和 48 小时均明显低于 B、C 组。在新肝阶段的 8 和 48 小时,A 组的 CD47 水平、ALT 和 AST 值均明显低于 B、C 组(P<0.05)。三组 CD47 水平与上述观察指标的趋势一致。通过减少炎症介质的释放,显著改善了受者的肝功能。本研究为肝移植 IRI 的治疗提供了新的思路和干预方法。